ImmuCell Corporation Deferred Tax Assets, Tax Deferred Expense, Other
ImmuCell Corporation (ICCC) had Deferred Tax Assets, Tax Deferred Expense, Other of $6.29 thousand as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2022-03-30
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $6.29K.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $8.81K.
- 2019-12-31: Deferred Tax Assets, Tax Deferred Expense, Other -$12.07K.
- 2018-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $13.35K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2021-12-31 | $6.29K 10-K · filed 2022-03-30 |
| 2020-12-31 | $8.81K 10-K · filed 2022-03-30 |
| 2019-12-31 | -$12.07K 10-K · filed 2020-03-27 |
| 2018-12-31 | $13.35K 10-K · filed 2020-03-27 |
| 2017-12-31 | $16.36K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |